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Our recent studies have shown that types of lymphomas and
leukaemias are determined by host genes in certain experimental
models (Yamada et al, 1994a, 1994b). Propylnitrosourea (PNU)-
induced T-lymphomas are one such example. F344 rats exhibit high
susceptibility, whereas many other strains of rats develop predomi-
nantly erythro- or myeloid leukaemias (Shisa and Hiai, 1985; Shisa
and Suzuki, 1991) We have assumed that a single dominant gene of
F344 rats determines the susceptibility to T-lymphomas and that
another independently segregating dominant gene determines the
length of the latency period (Shisa and Hiai, 1985). Subsequent
efforts to map such genes with crosses between F344 and LE rats,
however, have met with great difficulty (Shisa et al, unpublished
observation). The difficulty seems to arise partly from paucity of rat
genetic marker at that time and partly because these traits are quanti-
tative in nature and mutigenic, rather than a single gene inheritance.
The recombinant inbred (RI) strains represent a set of stable
inbred strains derived from F2 intercross between two parental
inbred stains. The RI strains are extremely useful for the genetic
analysis of complex traits (Taylor, 1978; Bailey, 1981). To analyse
T-lymphoma susceptibility, we have established a new set of rat RI
strains, LEXF, from matings between F344 and LE/Stm strains
rats. The LEXF RI strains comprise 11 independent strains and 13
of their sublines. The strain distribution pattern (SDP) of LEXF
has been extensively analysed (Shisa et al, 1997; Lu et al, 1998).
In this paper, we report the PNU-induced carcinogenesis in the
LEXF RI strains, and survey the host genes responsible for deter-
mination of the disease types and length of the latency period
calculated using quantitative trait locus (QTL) analysis with the
Map Manager QT software developed by Manly (1993). We found
that numerous QTL with opposed functions are involved in deter-
mining the types of lymphomas and latency periods. To control
type I and type II errors (Belknap et al, 1992, 1996), we further
evaluated these putative loci in 137 backcross generation of
(F344  ´ LE)F1 ´ LE rats. Significant linkage with T-lymphoma-
genesis was confirmed for three loci on chromosome 5, 7 and 10
and suggestive linkage, for a locus on chromosome 1.
MATERIALS AND METHODS
Animals
The LE/Stm rats were originally derived from a closed colony of
Long-Evans rats at Ben May Laboratory, University of Chicago
(Chicago, IL, USA) and maintained at Saitama Cancer Center
Research Institute by brother–sister matings for > 50 generations.
The F344 rats were derived from a pair of F344/DuCrj rats
purchased from Charles River Japan, Inc. (Kanagawa, Japan) and
thereafter maintained by brother–sister matings for > 23 genera-
tions. The LEXF was a set of 11 independent RI strains and 13
sublines (Shisa et al, 1997) In this study all LEXF RI strains except
for LEXF 6B, a poor breeder, were used. These sublines were
branched out at the 7th to 11th generations after an attempt to fix
coat colour. The main lines are designated either by the strain
number alone or by the number plus A when any sublines exist. The
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Between F344 and LE/Stm, approximately 38% of genetic loci are
polymorphic, and we have established the SDP of 153 loci (Shisa
et al, 1997; Lu et al, 1998). Among independent substrains, the
polymorphism ratio was 41~58%, and among sublines 12~18%.
The backcross rats were generated by mating (F344 ´ LE)F1 female
to LE male rats. All the rats were maintained under specific
pathogen-free conditions in our animal facility, kept at 24 ± 1°C.
PNU administration
PNU (Iwaki Kagaku Co. Ltd., Tokyo, Japan) was dissolved in de-
ionized water at a concentration of 400 mg ml–1 immediately
before use. All the rats were allowed access to PNU water ad
libitum from 17:00 h to 09:00 h, but no water was given after
09:00 h. The volume of PNU water consumed was measured daily
for estimation of the amount of PNU taken up. The rats were
inspected twice each week and weighed each week. The adminis-
tration of PNU was started at 40 days of age and continued for 90
days. Thereafter rats were given PNU-free water. All of the rats
were killed when they were moribund or at the age of 12 months,
and full autopsy including histopathological examination was
carried out. T-lymphomas were diagnosed by both involvement of
the thymus and expression of Thy-1.1 antigen on the surface of
tumour cells. Fluorescein isothiocyanate (FITC)-labelled anti-
Thy1.1 antibody was purchased from PharMingen (San Diego,
CA, USA). Staining and analysis of cells in a FACScan (Becton-
Dickinson, Mountain View, CA, USA) were carried out as
described previously (Lu et al, 1997). Other types of leukaemias,
without thymus enlargement and Thy1.1 expression, were
erythroid or myeloid leukaemias. Erythroid leukaemias, consisting
> 95% of Thy-1.1 negative non-T leukaemias, were diagnosed by
histology and cytology in stamp preparation as well as negative
peroxidase staining. In contrast, myeloid leukaemia cells had
azurophilic and peroxidase positive cytoplasmic granules and
variable expression of Gr-1 (PharMingen).
Genetic analysis
QTL analysis by interval mapping procedure was performed for
RI strains with Map Manager QT, a computer software package
developed and provided by Manly (1993). The Map Manager QT
applies one-way analysis of variance designed to identify
Mendelian loci that are significantly associated with quantitative
trait phenotype among mapped marker loci. The likelihood of ratio
statistic (LRS) calculated with the Map Manager QT is approxi-
mately equivalent to the c2 statistic. As a means of establishing
more reliable critical values for the significance of LRS generated
by the interval mapping procedures, 1000 times permutation test
(Manly, 1996) is built into the Map Manager QT. The minimum
values of LRS for suggestive, significant and highly significant
linkage are 7.8, 13.1 and 25.5 respectively. These values corre-
spond to the suggestions made by Lander and Kruglyak (1995).
Genotypes of all LEXF RI strains were based on the SDP table
published previously (Shisa et al, 1997; Lu et al, 1998).
A genome wide screening was carried out for 20 backcross rats
with T-lymphomas and another 20 rats with other leukaemias.
Assuming a radius of the swept circle 20 cM, the coverage was 88%.
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Table 1 PNU-induced leukaemias in LEXF RI strains
RI No. of rats All leukaemia T-lymphoma Other leukaemiaa
strains (%)
(%) Latency (%) Latency
(Days±s.d.) (Days±s.d.)
F344 29 28 (96.6) 28 (96.6) 106.6±15.6 0
LE 26 25 (96.2) 3 (11.5) 158.0±9.3 22 (84.6) 144.4±19.9
F1 25 25 (100) 24 (96.0) 126.5±25.1 1 (4.0) 152
1A 26 26 (100) 24 (92.3) 101.8±9.6 2 (7.7) 121.0±1.0
1B 26 26 (100) 26 (100) 110.5±17.7 0
1C 23 23 (100) 22 (95.6) 111.0±16.6 1 (4.3) 97
2A 21 21 (100) 6 (28.6) 107.5±8.0 15 (71.4) 112.6±7.1
2B 20 19 (95.0) 18 (90.0) 126.0±23.9 1 (5.0) 103
2C 20 19 (95.0) 17 (85.0) 128.4±25.6 2 (10.0) 132.5±8.5
2D 19 17 (89.5) 2 (10.5) 124.0±16.0 15 (78.9) 126±21.3
3 26 23 (88.5) 16 (61.5) 130.6±8.0 7 (26.9) 167.5±70.0
4 21 20 (95.2) 12 (57.1) 128.7±24.3 8 (38.1) 150.6±17.7
5 19 17 (89.5) 3 (15.8) 168.0±55.7 14 (73.7) 167.6±33.6
6A 26 25 (96.2) 18 (69.2) 139.0±29.2 7 (26.9) 174.1±54.1
7A 25 25 (100) 22 (88.0) 123.7±31.7 3 (12.0) 123.0±30.5
7B 20 19 (95.0) 11 (55.0) 125.3±17.0 8 (40.0) 176.1±33.1
7C 16 15 (93.8) 15 (93.8) 136.5±23.9 0
8A 17 14 (82.4) 2 (11.8) 153.5±15.5 12 (70.6) 173.2±35.2
8B 25 19 (76.0) 1 (4.0) 114 18 (72.0) 192.5±39.4
8C 20 17 (85.0) 2 (10.0) 233.0±10.0 15 (75.0) 148.6±31.2
8D 14 11 (78.6) 6 (42.9) 139.6±13.5 5 (35.7) 173.4±42.0
9 27 24 (88.8) 3 (11.1) 118.0±10.2 21 (77.8) 144.5±32.0
10A 30 28 (93.3) 24 (80.0) 130.7±30.5 4 (13.3) 163.7±10.2
10B 21 14 (66.7) 14 (66.7) 143.3±45.0 0
10C 21 21 (100) 16 (76.2) 141.5±32.7 5 (23.8) 165.2±33.2
11 25 24 (96.0) 24 (96.0) 116.7±33.0 0
aSee description in text.Statistical analysis
Chi-square test and unpaired Student’s t-test were used.
RESULTS
PNU-induced carcinogenesis in LEXF RI strains
Oral administration of PNU induced haemopoietic malignancies at
a high incidence in all of the LEXF RI strain rats (Table 1). The
overall incidence of leukaemias ranged from 66.7% to 100%
depending on the strain. Out of 508 LEXF RI rats, 466 (91.7%)
died of leukaemia. The types of leukaemias were T-lymphomas,
myeloid or erythroleukaemias, and their relative frequency varied
widely from one strain to another. Over 95% of non-T leukaemias
were erythroleukaemias. The T-lymphomas had the shorter latency
period: the latency period of 303 T-lymphomas was 132.7 ± 26.7
days, and that of 163 other leukaemias 148.0 ± 27.9 days (P =
1.1 ´ 10–8). F344 and (F344 ´ LE)F1 rats were highly susceptible
to T-lymphomas, and LE/Stm rats to non-T leukaemias. Figure 1
illustrates the frequency of such tumours among LEXF RI strains
in descending order of T-lymphoma incidence. Some LEXF RI
strains, showed higher susceptibility than the parental F344,
whereas that in other strains was lower than that in the LE/Stm
strain. This relation as well as the continuous spectrum of
PNU-induced lymphomas in LEXF RI strain rats 857
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Table 2 QTLs affecting T-lymphoma incidence
Relative Genotype of 23 RI strains Genotype of 11 independent RI strains
Loci distance LRS % T-lymphoma incidence ± s.d. P % T-lymphoma incidence ± s.d. P
(cM) (No. of strains) (No. of strains)
FL F L
D4Mgh8a 11.6 36.3±33.4 (10) 73.2±23.6 (13) 0.005 31.4±29.0 (5) 82.3±16.4 (6) 0.004
D7Wox24 7.5 3.1 66.3±24.5 (13) 42.2±40.0 (10) 0.09
D7Mit4 13.1 77.2±14.1 (10) 39.1±35.3 (13) 0.004 84.6±13.9 (5) 44.8±31.9 (6) 0.03
D7Mit5 2 7.2 71.2±24.4 (11) 41.1±35.9 (12) 0.03
D10Mgh3 13.2 6.2 44.2±34.9 (14) 78.0±16.9 (9) 0.01
D10Mgh6 6.7 43.5±32.7 (14) 79.1±17.6 (9) 0.007 43.4±32.1 (7) 86.8±16.3 (4) 0.04
D10Mgh8 2.3 6.4 43.8±34.6 (14) 78.4±17.1 (9) 0.01
D18Mit5a 11.5 36.3±36.1 (11) 73.2±19.9 (12) 0.005 44.0±39.5 (5) 71.8±26.2 (6) >0.05
aThe single locus within the linkage group.
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Figure 1 Percent incidence of T lymphomas (open column) and other types of leukaemias (closed columns) in the rats of LEXF RI strains, F344, LE/Stm and
(F344 ´ LE/Stm)F1T-lymphoma incidence suggested that the types of tumours were
determined by multiple genes. The proportions of T-lymphomas
and other leukaemias generally showed a reciprocal relationship,
but in the LEXF 1B, 11, 7C and 10B strains, no leukaemias other
than T-lymphomas were found.
In addition to lymphoma/laeukemia, PNU induced a variety of
non-haemopoietic tumours as diagnosed by histopathology.
Duodenal adenocarcinoma was found in 273/508 (53.7%) LEXF
RI rats. As duodenal cancers developed slightly later than
lymphoma/leukaemia, most leukaemia-free rats ultimately died
of duodenal cancers. Although the exact incidence was not
clear because of frequent concomitant development of
leukaemia/lymphoma, no apparent susceptibility difference was
found among strains. Low incidence (< 5%) of liver tumours
(haemangiomas and liver cell carcinomas), granulosa cell tumours
of ovary, renal cell carcinomas and ear duct cancers were found in
a few rats. The LEXF-9 strain was unique because mammary
carcinomas developed in ten of 17 female rats. No spontaneous
tumour was observed in any LEXF rats before 12 months of age.
QTL determining T-lymphoma development
Using T-lymphoma incidence as a quantitative parameter, we
surveyed potential host loci linked with susceptibility or resis-
tance. Table 2 lists the four linkage groups containing loci with
> 6.5 LRS calculated for 23 RI strains by Map Manager QT. On
the left half of the Table, the average incidence of T-lymphoma in
all 23 substrains is shown by either F344 or LE allele, and on the
right half, that in 11 independent substrains. Out of these four loci,
D18Mit5 (chromosome 18) was excluded since the differences in
T-lymphoma incidence in independent RI strains were not signifi-
cant. However, the differences were significant at D4Mgh8 (chro-
mosome 4), D7Mit4 (chromosome 7) and D10Mgh6 (chromosome
10) both for all RI strains and for independent strains. At D7Mit4,
F344-derived alleles favoured high T-lymphoma incidence (P =
0.004), whereas at D4Mgh8 and D10Mgh6, LE-derived alleles did.
Several LEXF strains showed considerable differences in T-
lymphoma incidence among their sublines. These sublines are
potentially informative in genetic analysis, because they are less
different from each other than from other independent RI strains.
As seen in Table 3, the T-lymphoma incidence was high in LEXF
2B (94.7%) and 2C (89.5%) but low in 2A (28.5%) and 2D
(11.8%). Among LEXF 8 sublines, T-lymphoma incidence was
42.9% in 8D but far lower in 8A, 8B and 8C. Such differences
were not explained by the three loci discussed above and D5Mit7,
as they were not so polymorphic among these sublines. This obser-
vation suggested the existence of other critical loci segregating
among these substrains. Examining the SDP table published previ-
ously (Lu et al, 1998), we found other loci, D12Mit1, D14Mit6 and
D16Mgh1, the alleles of which showed a strain distribution appar-
858 L-M Lu et al
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Table 3 T-lymphoma incidence among LEXF-2 and LEXF-8 sublines and alleles of some chromosomal loci
LEXF T-lymphoma
Genotype at marker locib
subline (%)a D4Mgh8 D5Mit7 D7Mit4 D10Mgh6 D12Mit1 D14Mit6 D16Mgh1 D18Mit5
2A 28.6 L L L F L L L L
2B 90 L L F F F F F L
2C 85 L L L F F F F L
2D 10.5 L L L F L L L F
8A 11.8 L L L F L F F F
8B 4 L L L F L F F F
8C 10 L L L F L F F F
8D 42.9 L L L F L L L F
aPercent incidence of T-lymphomas from Table 1. bGenotypes of all sublines from SDP table in Lu et al (1998). D4Mgh8, D7Mit7 and D10Mgh6 are selected
from QTL analysis of lymphoma incidence in 11 independent LEXF RI strains. The other four loci are selected by apparent association of lymphoma incidence
and genotype in SDP table.
Table 4 Loci affecting the length of T-lymphoma latency
Relative Genotype of RI strainsb and
Locia distance LRS T-lymphoma latency in days ± s.d. P
(cM) (No. of strains)
FL
D1Mit13 10.2 137.5 ± 5.5 (6) 122.0 ± 10.5 (10) 0.005
D1Wox9c 2.4 10.3 136.2 ± 5.6 (7) 121.2 ± 10.9 (9) 0.005
D5Mit7d 1.1 15.9 106.4 ± 6.51 (3) 131.54 ± 7.9 (13) 0.0002
D5Wox11 10.8 113.7 ± 13.5 (4) 131.8 ± 8.2 (12) 0.006
D5Wox4 2.4 9.4 116.8 ± 11.3 (5) 133.2 ± 7.0 (11) 0.01
D16Wox9e 14.4 114.5 ± 11.3 (5) 133.2 ± 7.0 (11) 0.001
aMarker loci within the linkage group containing the loci with highest LRS. bLEXF-2A, 2D, 5, 8A, 8B, 8C, 9 are excluded from calculation. cD1Wox9 shared the
same SDP for all 23 RI strains with D1Wox23 and D1Mit5. dD5Mit7 shared the same SDP pattern with D5Mit4 localized 3.8 cM proximal. eD16Wox9 shared the
same SDP with D16Wox10 and D16Wox11.ently associating with T-lymphoma incidence (Table 3). However,
LRS for T-lymphoma incidence in both 23 substrains and 11 inde-
pendent LEXF RI strains was < 6.5 at these loci (calculation not
shown). To address such differences, analysis of PNU-induced
tumours in crosses among these sublines is required.
Loci determining the latent period
Subsequently we searched for genes determining the length of the
latency period using the period (days) until T-lymphoma develop-
ment as a quantitative parameter. In this calculation, sublines with
< 3 rats bearing T-lymphomas were excluded. As shown in Table
4, there were three loci showing LRS > 10, one each on chromo-
some 1, 5 and 16. T-lymphomas in RI strains with F344 allele at
the loci on chromosome 5 and 16 had a significantly shorter
latency. In contrast, T-lymphomas in RI strains with F344 allele at
the locus on chromosome 1 had a slightly longer latency period.
The permutation test revealed that this locus fell within the sugges-
tive threshold values linked with the length of the latency period.
Analysis with backcross rats
Administration of PNU to 139 backcross rats to LE/Stm, 137
(98.6%) developed lympho-haemopoietic tumours, of which 94
were T-lymphomas and 43 erythroleukaemias. As the number of
independent LEXF RI strains was limited, we analysed genotype of
the backcross rats bearing each type tumours at the loci with any
suggestion of linkage for T-lymphoma incidence and their latent
period from the RI study. As summarized in Table 5, significant
linkage was observed at loci on chromosome 5 (c2 = 23.6 at
D5Mit7), chromosome 7 (c2 = 17.7 at D7Mit4) and chromosome 10
(c2 = 14.5 at D10Mgh6) respectively. Weak linkage was found at
D1Mit13 (c2 = 7.1). Among the backcross rats, T-lymphomas were
more frequent in heterozygotes for the loci on chromosome 5, 7 and
1, but less in LE allele homozygotes for the locus on chromosome
10. This was consistent with the observation in LEXF RI strains
(Table 2). The loci on chromosomes 1 and 5 were identified in RI
strains as loci affecting length of latency; however, in the backcross,
there was no significant difference in latency by genotype at these
loci (data not shown). To find other host genes involved in
lymphoma type determination, a genome wide screening of the
backcross population was carried out, but no linkage with c2 > 7 was
found except for three loci suggested by analysis of RI strains.
DISCUSSION
The type of lymphomas in rodents is determined either by
lymphomagenic agents or by host genetic constitution. In mice,
the primary determinant for T-lymphomas in AKR is the mink cell
focus forming (MCF) virus (Cloyd et al, 1980), which acquires
thymotropism and leukaemogenicity by successive recombina-
tions among endogenous proviruses (Stoye et al, 1991). Provirus
integration adjacent to certain host genes is also a determinant of
lymphoma/leukaemia types (Corcoran et al, 1984; Van Lohuizen
and Berns, 1990; Copeland and Jenkins, 1999). On the other hand,
effects of host genes on lymphoma type determination have been
amply recognized. Studying spontaneous lymphomas in AKXD RI
strains, Gilbert et al (1993) found that presence of MCF virus and
susceptibility allele of Rmcf (resistance to MCF virus) are impor-
tant for high T-lymphoma incidence. Also several other loci linked
to Car-2 (chromosome 3) and Pmv-25 (chromosome 4) associate
with high T-lymphoma frequency and Mtv-6 (chromosome 16),
with lower frequency (Gilbert et al, 1993). The inbred strain
SL/Kh is highly predisposed to pre-B-lymphomas (Shimada et al,
1993). In the cross between AKR and SL/Kh (Yamada et al,
1994b), we mapped a dominant gene Tism1 on mouse chromo-
some 7, which favours T-lymphoma over B-lymphoma suscepti-
bility. An AKR allele of Tlsm1 seems involved also in a
PNU-induced lymphomas in LEXF RI strain rats 859
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Table 5 Genetic analysis of the backcross rats
Genotype of backcross rats with
Loci Relative distance (cM) T-lymphoma Other leukaemias c2 P
F/L L/L F/L L/L
c 17.3 57 37 20 23 2.4 0.1
D1Mit13 2.4 51 42 13 30 7.1 0.008
D1Mit5 10 50 44 13 30 6.3 0.01
D1Mgh12 49 45 16 27 2.6 0.1
D4Mgh8 50 44 16 27 3 0.08
D5Mit4 3.8 59 35 15 28 9.2 0.002
D5Mit7 3.5 64 30 10 33 23.6 0.000001
D5Wox4 2.4 64 30 16 27 11.6 0.0007
D5Mgh8 60 34 18 25 5.8 0.02
D7Wox24 7.5 50 44 16 27 3 0.08
D7Mit4 2.0 56 38 9 34 17.7 0.00003
D7Mit5 55 39 13 30 9.4 0.002
D10Mgh3 7.6 41 49 27 15 4 0.05
D10Wox6 5.6 39 55 28 15 6.6 0.01
D10Mgh8 2.3 37 57 32 11 14.5 0.0001
D10Mgh8 40 54 29 14 7.3 0.007
D18Mit5 36 58 21 15 4.2 0.04predominance of T-lymphomas in some AKXD RI strains
(Yamada et al, 1994b). In the mice injected subcutaneously with
methylcolanthrene, the allelotype of aryl hydrocarbon hydroxylase
locus determines whether the tumours are lymphomas or sarcomas
at the injection site (Duran-Reynals, 1978). Em-myc transgene
induce B-lineage lymphomas (Harris et al, 1988) in many mouse
strains but in C3H, T-lymphomas  occur predominantly (Yukawa
et al, 1989), although the host gene responsible has not been
identified. Similar genetic determination of T-lymphomas is also
indicated in rats (Shisa and Hiai, 1985). Unlike mouse models,
involvement of endogenous retrovirus is less likely in the rat. The
action of these host genes is variable: e.g. affecting metabolic acti-
vation of carcinogen, virus propagation, DNA repair, differentia-
tion or proliferation of target cells, cell interactions in thymic
microenvironments, or immunologic surveillance to virus or
tumours. The genetic determination of disease types seems much
more intriguing than initially assumed.
Ogiu et al (1982) and we (Shisa and Hiai, 1985) found that F344
rats have high susceptibility to T-lymphoma induction by PNU,
while erythroid or myeloid leukaemias are predominant in most
other rat strains. Based on F2 and backcross data between F344
and LE/Stm, we initially assumed that a single dominant gene
of F344 determines susceptibility to T-lymphomas (Shisa and
Hiai, 1985). In LEXF RI strains, however, the incidence of T-
lymphomas showed a continuous array, suggesting involvement of
multiple genes in the type determination. To screen genes associ-
ated with high T-lymphoma incidence and length of latency
period, we performed QTL analysis. In QTL analysis, greater
precision is obtained when larger sample size (number of RI
strains in this case) is employed. To satisfy the criteria for statis-
tical significance, a marker locus should account for 40% of the
genetic variance in a QTL analysis with ten strains, but for only
20% in the same analysis with 20 strains (Plomin et al 1991). In
this study, we used a set of 23 substrains, of which 11 were inde-
pendent. A relatively small number of independent RI strains
poses a limitation on obtaining a high level of LRS, therefore, the
QTL analysis performed in LEXF RI strains were regarded as a
preliminary approach. To minimize type I error, all of potential
QTLs were re-evaluated by analysing data in the (F344 ´ LE)
´ LE backcross generation.
From the linkage analysis using Map Manager QT software,
seven loci were suggested by using the incidence and the length of
the latency of T-lymphoma development as parameters. Three of
them were found significantly associated with T-lymphoma-
genesis in 137 backcross rats. The first is a locus linked to D5Mit7,
which was originally identified by its effect on latency period. In
backcross analysis, the F344 allele at D5Mit7 highly significantly
favoured for T-lymphomas (P = 1 ´ 10–6), but the effect on
lymphoma latency was not significant. We postulated that it was
due to close correlation between T-lymphomas incidence and the
length of latency. In this segment, oncogene jun is located in the
order of D5Mit4-D5Mit5-jun-D5Mit7 (Pravenec et al, 1996). Jun
oncogene is essential to the efficient growth of certain tumours
(Angel et al, 1988). The second was D7Mit4, closely linked to
cellular oncogene myc. The gene order is D7Mit4-(2.9 cM)-myc-
(10 cM)-D7Mit5 (Pravenec et al, 1996). Similarly, F344 allele at
this locus favoured to form T-lymphoma (P = 0.00002). C-myc
plays a key role in the control of normal proliferation, transforma-
tion and differentiation. It is activated either by translocation (Janz
et al, 1993) or by retroviral integration (Selten et al, 1984) and is
thus involved in murine lymphomagenesis. The third gene is
linked to D10Mgh6, the LE allele homozygotes of this locus had a
higher T-lymphoma incidence (P = 0.0001).
Previously we reported that PNU-induced T-lymphomas in rats
is determined by a dominant gene Tls1 weakly linked with albino
(c) locus (Shisa and Hiai, 1985). In spontaneous lymphoma
models in mice, we found that the major dominant gene Tlsm1
determining development of T-lymphomas is located on mouse
chromosome 7, containing the syntenic segment of rat chromo-
some 1 (Yamada et al, 1994b). Therefore, we paid special attention
to rat chromosome 1. In the LEXF system, presence of a QTL
affecting the length of latency was suggested to associate with
D1Mit5, but this locus had a small effect on the T-lymphoma
development. Investigation of this segment of chromosome 1 in
backcross rats revealed a suggestive linkage with D1Mit13 (c2 =
7.1), located at 17.3 cM distal from c locus.
The loci on chromosome 4, 16 and 18 identified in RI strains did
not show linkage by analysis of backcross rats. Effect of MHC loci
on lymphoma latency is controversial in mouse models (Lilly and
Pincus, 1973; Chen and Lilly, 1982; Mucenski et al, 1986; Vasmel
et al, 1988; Kamoto et al, 1996). Resistance to virus or tumour
cells by the immune system is regulated by class II MHC loci. In
LEXF RI strains and backcross rats, however, no significant effect
of RT locus was observed (data not shown).
The RI strains of mice have been much used in the genetic study
of cancer, including applications to hemopoietic tumours of spon-
taneous origin (Dux et al, 1978; Bedigian et al, 1981; Gilbert et al,
1993; Yamada et al 1994b) or those induced by virus (Silver and
Fredrichson, 1983), radiation (Okumoto et al, 1990) and chemicals
(Potter et al, 1975). However, to our knowledge, this is the first
extensive study of chemical-induced lymphomagenesis with rat RI
strains. PNU was given to newly established LEXF RI strains rats.
All of the LEXF rats were highly susceptible to hemopoietic
malignancies but their types varied remarkably by substrain.
Preliminary QTL analysis identified several host genes affecting
susceptibility to T-lymphomas and length of latency period. Those
loci were further confirmed by analysis of backcross rats derived
from the same parental strains. The number of independent RI
substrains is small, the precision of gene mapping is limited but
the information of such loci is still valuable for further investiga-
tion. A variety of non-haemopoietic tumours developed in RI rats,
of which duodenal cancers were representative. These tumours
developed concomittantly or slightly later than haemopoietic
tumours, so that genetic analysis for them is difficult. The most
promising use of the LEXF RI strains would be to dissect host
genes involved in haemopoietic tumours.
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